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Left Atrial Malignant Fibrous Histiocytoma with Right 
Atrium Invasion 
 
Abstract 
Background: Primary cardiac tumors are rare (0.001 to 0.03%). Malignant tumors account 
for 25%, of which 75% are cardiac sarcomas. 
Case Persentation: Here, we report a case of a 57-year-old male with palpitation and 
history of left atrial (LA) myxoma resection presented to cardiology clinic for postsurgical 
follow up and transthoracic echocardiography revealed a large non-homogenous mass in 
LA with right atrium invasion, which was confirmed by trans-esophageal echocardiography. 
The patient underwent surgical resection of tumor and the pathological diagnosis was 
malignant fibrous histiocytoma (MFH). 
Conclusion: MFH could be asymptomatic and the diagnosis be established as a surgical or 
complementary examination. In patients with history of myxoma resection and cardiac 
masses, further evaluation is recommended. 
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Primary cardiac sarcomas are rare tumors that represent 20% of all primary cardiac 
tumors (1) and constitute the most common subtype (75%) of cardiac malignant tumors 
(2). These patients most commonly present with palpitation and dyspnea, but some are 
asymptomatic and diagnosed incidentally (3). Although malignant tumors are usually 
detectable with echocardiography, the diagnosis of sarcoma is rarely made until after 
surgical intervention (2). Potential complications are arrhythmia, thrombosis, pulmonary 
embolism and rupture of the dilated appendage (4, 5). The disease is poor prognosis with a 
mean survival of 9.6 to 16.5 months (1, 2, 6, 7). Although adjuvant chemotherapy and 
radiotherapy have been used, the standard treatment remains complete surgical resection of 
tumor (2). We present a case of malignant fibrous histiocytoma in a 57-year old man. 
 
Case presentation 
A 57-year-old man with the history of left atrial (LA) myxoma presented to cardiology 
clinic every 6-month follow-up visit. He underwent LV myxoma resection 2 years ago. He 
had palpitation, but did not suffer from chest pain or dyspnea. Past medical history was 
positive for smoking with no history of chest trauma. On physical exam, the patient was 
awake; he had a regular S1 S2 with a S4 gallop, with normal breathing sounds all over the 
lungs. Initial EKG was normal without ischemic changes. The chest radiography showed 
global enlargement of the cardiac area and distributed broncovascular view. Transthoracic 
echocardiogram (TTE) was performed, revealing a normal right and left ventricular size 
and function (LVEF= 55-60%), and a large non-homogenous mass with lucent part within 
it suggestive of infarct part of tumor attached to interatrial septum (6×4cmm, mass 
area=13cm
2
) (figure 1), most probably myxoma, severe eccentric MR due to prolaptic P2 
scallop, moderate TR, RVSP=70 mmHg, severe PH, and mild PI. 
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These findings were confirmed by trans-esophageal 
echocardiography (TEE). The right atrium was normal and 
on Doppler study, significant diastolic restriction to the 
filling flows of both ventricles was not found. Pulmonary CT 
angiography with 64 multi-slice CT scan and VRT and MIP 
reconstruction revealed a soft tissue within LA with 78 mm 
diameter with LA expansion and pressure effect on 
neighboring chambers. There was single lymph node in 
thorax inlet (31 mm). There was not pulmonary, lobar and 
segmental main artery feeling defect. Laboratory 
examinations were normal except for high level of serum 
pro-BNP (33964 pg/ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. TEE midesophageal view; A: large semimobile 
non-homogenous mass in LA attached to IAS with size 
5.74 *4.17 cm. B: large non homogenous mass in LA 
attached to IAS with lucent part within it.  C: TEE 
midesophageal view in 77 ' showed: non-homogenous 
mass in La with extension to left pulmonary veins. 
The patient underwent surgical resection of tumor. 
Tumor resection was performed with the patient under 
cardiac arrest with cardiopulmonary bypass. Pathology 
results showed proliferation of neoplastic spindle- shaped 
fibroblastic cells having fascicular patterns or arranged 
haphazardly with scattered multinucleated giant cells. The 
cells have pink cytoplasms and atypical fusiform nuclei 
(figure 2); all indicative of malignant fibrous histiocytoma 
(MFH). After operation and moving to ICU, the patient was 
complicated by high grade fever, pneumonia, increasing 
BUN and creatinine and finally, acute renal failure. 
Unfortunately the patient expired 3 days after the operation 
with ARF and respiratory failure associated with 
pseudomonas pneumonia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Pathologic studies: proliferation of neoplastic 
spindle- shaped fibroblastic cells having fascicular 
patterns or arranged haphazardly with scattered 
multinucleated giant cells. The cells have pink cytoplasms 
and atypical fusiform nuclei (H&E ×400). 
 
 
Discussion 
Most of adult primary cardiac tumors are benign (75%). 
Moreover, 50% of RA primary tumors are malignant while a 
majority of LA tumors are benign and mostly consist of 
myxomas (50–75%) (8).  
Primary cardiac sarcomas are rare and represent 20% of 
all primary cardiac tumors. Symptoms depend on the 
chambers and the cardiac structures involved. Transthoracic 
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echocardiography is commonly used to identify a cardiac 
mass. Primary MFH has been reported as the second most 
common primary cardiac sarcoma which usually occurs at 
age range of 14 to 77 years (9).  
Undifferentiated sarcomas account for one-third of all 
cardiac sarcomas and have been incorporated in the 
malignant fibrous histiocytoma/ pleomorphic sarcoma 
subgroup (1, 2). Cardiac MFH occur and is defined more 
frequently in LA (9). 
 The case we report differs from those in the consulted 
literature in regard to anatomical features and more extended 
tumor size, as presented with involvement of LA and RA 
wall. As reported in previous literature, the patient may be 
asymptomatic and the diagnosis was established as a surgical 
or complementary examination (3). 
 Our patient had only palpitation and the diagnosis was 
made by transthoracic echocardiography and contrast TEE 
led to accurate diagnosis. Elective treatment regimen of 
cardiac sarcoma includes complete surgical excision when 
possible, followed by radiotherapy and chemotherapy (1). 
The presented case was interesting for the presence of huge 
LA malignant fibrous histiocytoma with RA invasion; so, 
individualization of the treatment according to clinical 
features and complementary examinations (valuing the 
presence of thrombi, compression of adjacent structures, and 
associated diseases) was required.  
Therefore after discussing the treatment options with the 
patient, we decided for surgical tumor resection. As 
mentioned, the prognosis of cardiac sarcomas is very poor 
(6, 7). However, our case was complicated and expired 3 
days after the operation. 
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